191 related articles for article (PubMed ID: 34958011)
21. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
[TBL] [Abstract][Full Text] [Related]
22. Shear wave elastography of thyroid nodules for the prediction of malignancy in a large scale study.
Park AY; Son EJ; Han K; Youk JH; Kim JA; Park CS
Eur J Radiol; 2015 Mar; 84(3):407-412. PubMed ID: 25533720
[TBL] [Abstract][Full Text] [Related]
23. Shear wave elastography combined with the thyroid imaging reporting and data system for malignancy risk stratification in thyroid nodules.
Liu Z; Jing H; Han X; Shao H; Sun YX; Wang QC; Cheng W
Oncotarget; 2017 Jun; 8(26):43406-43416. PubMed ID: 28160573
[TBL] [Abstract][Full Text] [Related]
24. Three-Dimensional Shear Wave Elastography for Differentiating Benign From Malignant Thyroid Nodules.
Zhao CK; Chen SG; Alizad A; He YP; Wang Q; Wang D; Yue WW; Zhang K; Qu S; Wei Q; Xu HX
J Ultrasound Med; 2018 Jul; 37(7):1777-1788. PubMed ID: 29315789
[TBL] [Abstract][Full Text] [Related]
25. Proper indication of BRAF(V600E) mutation testing in fine-needle aspirates of thyroid nodules.
Koh J; Choi JR; Han KH; Kim EK; Yoon JH; Moon HJ; Kwak JY
PLoS One; 2013; 8(5):e64505. PubMed ID: 23717622
[TBL] [Abstract][Full Text] [Related]
26. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
[TBL] [Abstract][Full Text] [Related]
27. Incidence and predictive factors of inadequate fine-needle aspirates for BRAF(V600E) mutation analysis in thyroid nodules.
Lee KH; Kim HS; Han BK; Ko EY; Ki CS; Shin JH
AJR Am J Roentgenol; 2014 Feb; 202(2):391-6. PubMed ID: 24450682
[TBL] [Abstract][Full Text] [Related]
28. Initial clinical experience with BRAF(V600E) mutation analysis of core-needle biopsy specimens from thyroid nodules.
Choi SH; Baek JH; Lee JH; Choi YJ; Ha EJ; Song DE; Kim JK; Chung KW; Kim TY; Kim WB; Shong YK
Clin Endocrinol (Oxf); 2016 Apr; 84(4):607-13. PubMed ID: 26215382
[TBL] [Abstract][Full Text] [Related]
29. Fine-needle Aspiration Washout Precipitation Specimens: An Acceptable Supplement to Genetic Mutation Detection of Thyroid Nodules.
Cui Y; Huang X; Guo J; Zhang N; Liang J; Zhang Y; Liao Y; He D
Technol Cancer Res Treat; 2021; 20():15330338211057982. PubMed ID: 34806478
[No Abstract] [Full Text] [Related]
30. Predicting malignancy in thyroid nodules based on conventional ultrasound and elastography: the value of predictive models in a multi-center study.
Zhang Y; Huang QY; Wu CJ; Chen Q; Xia CJ; Liu BJ; Liu YY; Zhang YF; Xu HX
Endocrine; 2023 Apr; 80(1):111-123. PubMed ID: 36495391
[TBL] [Abstract][Full Text] [Related]
31. Shear wave elastography of thyroid nodules in routine clinical practice: preliminary observations and utility for detecting malignancy.
Bhatia KS; Tong CS; Cho CC; Yuen EH; Lee YY; Ahuja AT
Eur Radiol; 2012 Nov; 22(11):2397-406. PubMed ID: 22645042
[TBL] [Abstract][Full Text] [Related]
32. BRAF
Zhao CK; Zheng JY; Sun LP; Xu RY; Wei Q; Xu HX
Cancer Med; 2019 Sep; 8(12):5577-5589. PubMed ID: 31397092
[TBL] [Abstract][Full Text] [Related]
33. Significance of FNAC, BRAF mutation, and intraoperative frozen section in surgical decision-making of thyroid nodules.
Zhu Z; Su C; Chen G; Wan F; Jin M; Duan X; Wang Y; Wang G
Diagn Cytopathol; 2023 Jul; 51(7):441-448. PubMed ID: 37042168
[TBL] [Abstract][Full Text] [Related]
34. The mutational analysis in the diagnostic work-up of thyroid nodules: the real impact in a center with large experience in thyroid cytopathology.
Macerola E; Rago T; Proietti A; Basolo F; Vitti P
J Endocrinol Invest; 2019 Feb; 42(2):157-166. PubMed ID: 29704233
[TBL] [Abstract][Full Text] [Related]
35. [Clinical role of BRAF V600E mutation testing in thyroid nodules].
Wan H; Zhang B; Wang Y; Xiao T; Guo H; Liu W; Yan D; Xu Z; Tang P
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jun; 49(6):468-72. PubMed ID: 25241863
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of thyroid micro-carcinoma using shear wave elastography: Initial experience with qualitative and quantitative analysis.
Tan S; Sun PF; Xue H; Fu S; Zhang ZP; Mei F; Miao LY; Wang XH
Eur J Radiol; 2021 Apr; 137():109571. PubMed ID: 33636489
[TBL] [Abstract][Full Text] [Related]
37. [Diagnostic values of BRAF(V600E) mutation analysis and Bethesda system for reporting thyroid cytopathology in thyroid nodules with TIRADS 4 and 5].
Han Y; Zhao BW; Li SY; Lyu JG; Shou JD; Xu HS; Lou HY; Xu LL; Gao L; Xu SX; Zhu J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 52(9):686-691. PubMed ID: 28910894
[No Abstract] [Full Text] [Related]
38. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
Lee ST; Kim SW; Ki CS; Jang JH; Shin JH; Oh YL; Kim JW; Chung JH
J Clin Endocrinol Metab; 2012 Jul; 97(7):2299-306. PubMed ID: 22500044
[TBL] [Abstract][Full Text] [Related]
39. Differential diagnosis of diffuse sclerotic thyroid papillary carcinoma and Hashimoto's thyroiditis using fine-needle aspiration cytology, BRAF
Wang X; Xu F; Gao J; Agyekum EA; Sun H; Zhang G; Li X; Xiang H; Hu S; Qian X
J Clin Ultrasound; 2022 Sep; 50(7):942-950. PubMed ID: 35779272
[TBL] [Abstract][Full Text] [Related]
40. SWE combined with ACR TI-RADS categories for malignancy risk stratification of thyroid nodules with indeterminate FNA cytology.
Zhang WB; Li JJ; Chen XY; He BL; Shen RH; Liu H; Chen J; He XF
Clin Hemorheol Microcirc; 2020; 76(3):381-390. PubMed ID: 32675401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
